The progress made in liver disease research to date presents an opportunity for further advancements in the near future.

Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant ...

That’s it for 2025’s Q1 clinical trials round-up. If you have a study that could fit the bill for our next column, please ...

Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...

Just a few months after announcing a plan to separate its drug and cell therapy businesses into two separate companies, ...

Netherlands biotech Azafaros is poised to start phase 3 trials of its lead drug for a trio of rare lysosomal storage ...

In the REAL8 basket trial, Sogroya (somapacitan), administered as a once-weekly subcutaneous injection, was at least as ...

Improving Global Access to Life-Changing Therapeutics... Following the successful Boston and London meetings, the ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...

A digital therapy that could reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use ...

Moreover, Downing Street has indicated that the UK will receive "preferential treatment in any further tariffs imposed" as ...